Form 8-K - Current report:
SEC Accession No. 0001193125-25-232562
Filing Date
2025-10-07
Accepted
2025-10-07 07:13:40
Documents
53
Period of Report
2025-10-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d58004d8k.htm   iXBRL 8-K 45546
2 EX-4.1 d58004dex41.htm EX-4.1 85020
3 EX-10.1 d58004dex101.htm EX-10.1 267794
4 EX-10.2 d58004dex102.htm EX-10.2 88760
5 EX-99.1 d58004dex991.htm EX-99.1 12212
6 EX-99.2 d58004dex992.htm EX-99.2 19251
7 EX-99.3 d58004dex993.htm EX-99.3 47076
11 GRAPHIC g58004ex99_3p10g1.jpg GRAPHIC 240593
12 GRAPHIC g58004ex99_3p11g1.jpg GRAPHIC 368063
13 GRAPHIC g58004ex99_3p12g1.jpg GRAPHIC 342035
14 GRAPHIC g58004ex99_3p13g1.jpg GRAPHIC 267898
15 GRAPHIC g58004ex99_3p14g1.jpg GRAPHIC 290488
16 GRAPHIC g58004ex99_3p15g1.jpg GRAPHIC 338879
17 GRAPHIC g58004ex99_3p16g1.jpg GRAPHIC 232123
18 GRAPHIC g58004ex99_3p17g1.jpg GRAPHIC 340347
19 GRAPHIC g58004ex99_3p18g1.jpg GRAPHIC 326681
20 GRAPHIC g58004ex99_3p19g1.jpg GRAPHIC 328540
21 GRAPHIC g58004ex99_3p1g1.jpg GRAPHIC 174783
22 GRAPHIC g58004ex99_3p20g1.jpg GRAPHIC 317884
23 GRAPHIC g58004ex99_3p21g1.jpg GRAPHIC 402454
24 GRAPHIC g58004ex99_3p22g1.jpg GRAPHIC 139017
25 GRAPHIC g58004ex99_3p23g1.jpg GRAPHIC 415263
26 GRAPHIC g58004ex99_3p24g1.jpg GRAPHIC 269469
27 GRAPHIC g58004ex99_3p25g1.jpg GRAPHIC 231277
28 GRAPHIC g58004ex99_3p26g1.jpg GRAPHIC 284209
29 GRAPHIC g58004ex99_3p27g1.jpg GRAPHIC 332407
30 GRAPHIC g58004ex99_3p28g1.jpg GRAPHIC 301202
31 GRAPHIC g58004ex99_3p29g1.jpg GRAPHIC 251484
32 GRAPHIC g58004ex99_3p2g1.jpg GRAPHIC 656204
33 GRAPHIC g58004ex99_3p30g1.jpg GRAPHIC 357011
34 GRAPHIC g58004ex99_3p31g1.jpg GRAPHIC 133457
35 GRAPHIC g58004ex99_3p32g1.jpg GRAPHIC 226417
36 GRAPHIC g58004ex99_3p33g1.jpg GRAPHIC 275451
37 GRAPHIC g58004ex99_3p34g1.jpg GRAPHIC 125399
38 GRAPHIC g58004ex99_3p35g1.jpg GRAPHIC 168363
39 GRAPHIC g58004ex99_3p3g1.jpg GRAPHIC 286260
40 GRAPHIC g58004ex99_3p4g1.jpg GRAPHIC 152025
41 GRAPHIC g58004ex99_3p5g1.jpg GRAPHIC 286190
42 GRAPHIC g58004ex99_3p6g1.jpg GRAPHIC 347792
43 GRAPHIC g58004ex99_3p7g1.jpg GRAPHIC 343011
44 GRAPHIC g58004ex99_3p8g1.jpg GRAPHIC 292016
45 GRAPHIC g58004ex99_3p9g1.jpg GRAPHIC 349753
  Complete submission text file 0001193125-25-232562.txt   14878819

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA jbio-20251003.xsd EX-101.SCH 2845
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE jbio-20251003_lab.xml EX-101.LAB 19498
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jbio-20251003_pre.xml EX-101.PRE 12152
56 EXTRACTED XBRL INSTANCE DOCUMENT d58004d8k_htm.xml XML 3938
Mailing Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453 (781) 312-3013
Jade Biosciences, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 251378249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)